Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Two new studies have been published that further focus attention on how the renin–angiotensin ...

The argument was elegant in its simplicity. Patients with high levels of renin had a vasoconstriction type of hypertension that was driven primarily by the actions of the renin-angiotensin system on ...

The renin-angiotensin system (RAS) remains a cornerstone of cardiovascular and renal physiology, orchestrating vital aspects of blood pressure regulation and fluid-electrolyte balance. At the heart of ...

Forbes contributors publish independent expert analyses and insights. I'm a medical journalist covering cardiology news. The enormous success of ACE inhibitors in hypertension and heart failure ...

New Orleans, La. (March 27, 2007) -- A combination of two medicines that act against the effects of the enzyme renin are more effective in lowering blood pressure than either of the medicines alone, ...

Please provide your email address to receive an email when new articles are posted on . RAS blockers had similar mortality benefit by race in patients with HFrEF. RAS blockers improved HF ...

ACE inhibitors and angiotensin-receptor blockers have been found to effectively slow progression of kidney disease. It has been theorized that dual blockade of the renin-angiotensin-aldosterone system ...

Fourteen normotensive and 14 hypertensive black men with mild essential low-renin hypertension were examined during two protocols producing sodium depletion (less than 40 mmol sodium diet per day) for ...

In a recent study posted to the medRxiv* preprint server, researchers conducted an umbrella review and meta-analysis of the renin-angiotensin-aldosterone system (RAAS) inhibitors' impact on ...

This is a preview. Log in through your library . Abstract Angiotensin II is the principle effector molecule of the renin angiotensin System (RAS). It exerts its various actions on the cardiovascular ...

The FDA approved aliskiren, the first hypertension treatment that inhibits renin. Aliskiren (Tekturna, Novartis) is also the first, new type of hypertension drug approved by the FDA in more than a ...